Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
A Camelid-Derived STAT-Specific Nanobody Inhibits Neuroinflammation and Ameliorates Experimental Autoimmune Encephalomyelitis (EAE).
Journal: Cells
Published: May 03, 2024
Overcoming Acquired Drug Resistance to Cancer Therapies through Targeted STAT3 Inhibition.
Journal: International journal of molecular sciences
Published: February 01, 2023
A Broad-Based Characterization of a Cell-Penetrating, Single Domain Camelid Bi-Specific Antibody Monomer That Targets STAT3 and KRAS Dependent Cancers.
Journal: International journal of molecular sciences
Published: May 30, 2022
Suppression of Breast Cancer Cell Proliferation by Selective Single-Domain Antibody for Intracellular STAT3.
Journal: Breast cancer : basic and clinical research
Published: July 18, 2017
Showing 1-5 of 5
Last Updated: 09/26/2026